Open Beta
TREN
MetriLume
TREN

US marketsCRDF

SEC-sourced researchBeta

CRDF

Cardiff Oncology, Inc.

Company comparison ↗

Data passport

CIK
0001213037
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 14, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 683,000.0000 USD; December 2025: 593,000.0000 USD683K USD0 USD0December 2024December 2025
CRDF · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024683,000.0000Feb 24, 2026
December 2025593,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025593,000.0000-45,851,000.0000-37,923,000.000061,884,000.000016,496,000.0000Feb 24, 2026
December 2024683,000.0000-45,431,000.0000-37,693,000.000097,190,000.000014,241,000.0000Feb 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$593KDecember 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$683KDecember 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$45.85MDecember 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$37.92MDecember 2025Feb 24, 202610-K
Total assetsAssets$61.88MDecember 2025Feb 24, 202610-K
Total liabilitiesLiabilities$16.5MDecember 2025Feb 24, 202610-K

New filings

Explore methodology ↗